CD22 and primary cutaneous T-cell non-Hodgkin lymphoma: Indeed, flow cytometry analysis using another anti-CD22 mAb, FR10B4, revealed a positive staining in all of the four malignant CTCL cell lines including the MyLa2059 and PB2B cell lines (Fig. 1D, and data not shown).